Fas gene promoter −670 polymorphism (A/G) is associated with cervical carcinogenesis
- 31 July 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 98 (1) , 129-133
- https://doi.org/10.1016/j.ygyno.2005.04.001
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- No evidence of the involvement of the Fas −670 promoter polymorphism in cervical cancer in situInternational Journal of Cancer, 2004
- Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesisInternational Journal of Cancer, 2002
- Up-regulation of Fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillanceHepatology, 2000
- Establishment and Characterization of a New HPV-Negative Squamous Cell Carcinoma Cell Line (Yumoto) from the Human Uterine CervixGynecologic Oncology, 1998
- Apoptosis by Death FactorCell, 1997
- Association of Multiple Human Papillomavirus Types with Vulvar NeoplasiasJournal of Obstetrics and Gynaecology Research, 1996
- Identification of a Silencer, Enhancer, and Basal Promoter Region in the Human CD95 (Fas/APO-1) GeneDNA and Cell Biology, 1995
- Expression of Fas Antigen on Keratinocytes In Vivo and Induction of Apoptosis in Cultured KeratinocytesJournal of Investigative Dermatology, 1994
- Detection and Typing of Multiple Genital Human Papillomaviruses by DNA Amplification with Consensus PrimersJapanese Journal of Cancer Research, 1991
- Structure and Expression of an Integrated Human Papillomavirus Type 16 Genome Amplified in a Cervical Carcinoma Cell LineJournal of General Virology, 1989